-+ 0.00%
-+ 0.00%
-+ 0.00%

Spero Therapeutics Appoints William Ho to Board of Directors

PUBT·11/10/2026 13:01:52
Listen to the news
Spero Therapeutics Appoints William Ho to Board of Directors
  • Spero Therapeutics appointed William Ho to its board and Development Committee, effective November 10, 2026.
  • Ho replaces Patrick Vink, who is stepping down from the board following an 11-year tenure.
  • Ho served as RAPT Therapeutics’ chief medical officer from 2015 to December 2025, with over 20 years of clinical development experience.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spero Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611100800PRIMZONEFULLFEED9874121) on November 10, 2026, and is solely responsible for the information contained therein.